| Literature DB >> 28487136 |
Joyita Banerjee1, Vijay Nema2, Yogita Dhas1, Neetu Mishra3.
Abstract
Type 2 diabetes mellitus (T2DM) has become a major health threat worldwide. MicroRNAs (miRNAs) are a group of non-coding RNAs known to regulate various biological processes including the pathogenesis of T2DM. Recent studies have pointed out that specific miRNAs play a critical role in controlling β cell activities and the development of diabetic vascular complications. Their association with the disease pathogenesis and omnipresence in body fluids have made them important players for prognosis, diagnosis and management of T2DM. Owing to the limitations of classical biomarkers of diabetes such as fasting plasma glucose, glycosylated haemoglobin (HbA1c) lack in predicting the risk of development of diabetes complications in a susceptible population. The miRNAs can act as ideal biomarkers for diabetes associated complications. Identification of specific miRNA signatures to detect diabetes and ideally to find out the risk of development of diabetes-associated complications in susceptible population is the essential requirement of the present clinical strategies for controlling diabetes worldwide. In this article, we summarize the potential miRNAs and miRNA signatures involved in the β cell activities and diabetes associated macrovascular and microvascular complications.Entities:
Keywords: Macrovascular complications; Microvascular complications; Type 2 diabetes mellitus; microRNAs; β cell activities
Mesh:
Substances:
Year: 2017 PMID: 28487136 DOI: 10.1016/j.biochi.2017.05.007
Source DB: PubMed Journal: Biochimie ISSN: 0300-9084 Impact factor: 4.079